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Background: The relative effects of the mass, volume and
concentration of local anaesthetic solution used for epidural
anaesthesia and analgesia are still under debate. Clinical
studies have shown discrepancies, probably because of limited
consideration of total dose.
Methods: This prospective, randomized and blinded study
evaluated the spread, the quality of post-operative analgesia
and the incidence of side-effects of continuous thoracic
epidural levobupivacaine 15mg/h in three different concentra-
tions: 1.5mg/ml, 10ml/h (n¼ 26), 5mg/ml, 3ml/h (n¼ 33) or
7.5mg/ml, 2ml/h (n¼ 31). The following variables were regis-
tered within 48 h: sensory block, pain scores, rescue morphine
consumption, motor blockade, haemodynamics, sedation,
nausea and vomiting, and patient satisfaction.
Results: The three groups were similar with regard to demo-
graphics, quality of analgesia, morphine consumption, and
satisfaction rate. The upper level of sensory block was two
segments higher in the 1.5mg/ml group. Motor blockade in
the lower limbs was low in the three groups. Haemodynamic
profile was more stable in the higher concentration groups
compared with the 1.5mg/ml patient group (P< 0.001).
Nausea was more frequent in the 1.5mg/ml group (P¼ 0.02).
Conclusion: The same dose of levobupivacaine provides an
equal quality of analgesia in low or high volume continuous
thoracic epidural infusion with reduced haemodynamic
instability and nausea in the low volume/high concentration
groups.
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THE relative effects of the mass, volume and con-centration of local anaesthetic solution used for
epidural anaesthesia and analgesia are still under
debate. In clinical studies (1—5), discrepancies
appeared probably caused by the fact that the total
dose of local anaesthetic was not taken into consid-
eration. Bromage (6) found that it is the total local
anaesthetic dose, and not the total volume, that deter-
mines the spread and quality of analgesia. This has
been confirmed by others, after both lumbar (7) and
mid-thoracic (8) epidural administration. For con-
tinuous thoracic epidural administration, Dernedde
et al. (9) demonstrated in a pilot study, that a high
concentration/low volume of local anaesthetic pro-
vided equal quality of post-operative analgesia as
a low concentration/high volume infusion and
induced less motor blockade and haemodynamic
repercussions. Nevertheless, it remains debatable in
literature, whether the concentration influences the
quality of pain relief during epidural analgesia, as
long as the total dose is constant (10—12).
To confirm the findings that the spread and the
quality of epidural analgesia depend on the total
mass of local anaesthetic and not on the volume or
concentration, we designed a prospective, random-
ized and blinded study to compare three different
concentrations of levobupivacaine (1.5, 5 and 7.5
mg/ml), given as an equal hourly dose continuous
infusion after lower abdominal surgery.
Methods
After approval by the Ethics Committee, written
informed consent was obtained from 99 consecutive
ASA physical status I to III patients undergoing
elective lower abdominal surgery. Patients were
included if they were 18—75years old, able to read
and understand French, with normal mental health
and hospitalized for elective surgery. Exclusion
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criteria were sepsis, allergy to amide-type local anaes-
thetics or morphine and coagulopathy. At the time of
the pre-operative visit, patients were familiarized
with a 10-cm visual analogue scale (VAS) device for
pain (0¼no pain at all, 10¼worst imaginable pain)
and nausea (0¼no nausea at all, 10¼worst imagin-
able nausea) intensity assessment (13).
Patients were premedicated with midazolam
3—6mg administered intramuscularly 1h before
induction of anaesthesia or alprazolam 0.5—0.75mg
orally in the morning of the intervention. In the
operating room, after infusion of 500ml of Ringer’s
lactate solution via an intravenous canula, a 20-gauge
epidural catheter was inserted through an 18-gauge
Tuohy needle into the epidural space at low thoracic
levels. The epidural catheter was directed cephalad
for a distance of 4 cm and fixed to the back of the
patient. As soon as the patient was in a supine pos-
ition, a test dose of 3ml of 5mg/ml levobupivacaine
(Chirocaine1, Abbott, Belgium) was injected through
the catheter (14, 15). Bilateral sensory anaesthesia was
demonstrated by pinprick after the test dose.
Anaesthesia was maintained with sevoflurane in
50% oxygen in air or nitrous oxide associated with
sufentanil and myorelaxant. Based on an anti-emetic
institutional policy (16), tropisetron (Novaban1,
Novartis, Brussels, Belgium) 2mg was administered
to all patients. Three to 6ml of 5mg/ml levobupiva-
caine was injected through the epidural catheter for
the surgical procedure. If surgery lasted longer than
2h, patients received a reinjection of half of the
volume of the local anaesthetic using the same con-
centration. After completion of the operation and tra-
cheal extubation, patients were transferred to the
post-anaesthesia care unit (PACU) where they
remained under constant observation for approxi-
mately 4h. The patients received in a random fashion
using a computer-generated random number table,
1.5mg/ml levobupivacaine 10ml/h (n¼ 31),
5mg/ml levobupivacaine 3ml/h (n¼ 33) or
7.5mg/ml levobupivacaine 2ml/h (n¼ 35) for post-
surgical pain relief via an infusion pump (Abbott
aim1 plus, Abbott Laboratories, North Chicago, IL).
No extra bolus injection or change of the infusion
rate was allowed. Patients received multimodal
analgesia consisting of 6-hourly intravenous pro-
pacetamol (2 g) and ketorolac (60mg daily) for post-
operative pain relief. Rescue medication by means of
morphine was provided via a patient-controlled
analgesia device (Abbott Lifecare PCA Infusor, Abbott
Laboratories) with 1.5-mg bolus doses, a 7-min lockout
time, and a 25-mg dose limit over 4h without loading
dose. The consumption of analgesic drugs was
recorded during the 48-h study period. After 48h,
the infusion of levobupivacaine was discontinued
and alternative analgesia was provided.
Upon arrival in the PACU, patients were asked to
rate their pain experience on the VAS device. This
process was repeated every 2h for the first 4 h, and
when the patient moved to the general surgical ward,
it was continued every 4h for 48h. Only rest pain was
assessed, defined as the pain experienced by the
patient while lying in bed. The pain threshold was
set at 3 cm on the VAS scale (17). Nausea intensity
was evaluated using a VAS device and vomiting was
recorded as either present or absent by direct obser-
vation or by spontaneous complaint of the patient.
Nausea was defined as a patient’s rating score super-
ior to 4 cm on the VAS (13). Rescue medications given
for nausea and/or vomiting were recorded. Motor
blockade in the lower limbs was assessed according
to a modified Bromage scale (18) (0¼no motor block,
1¼ inability to flex hips, 2¼ inability to flex knees,
3¼ inability to flex ankle joints). The cephalad level of
sensory block was evaluated by loss of sensation to
cold using ether swabs at the same time. If the levels
of sensory block on the right and left sides were
different, the most cephalad was recorded. Nurses,
who were blinded to the type of epidural solution,
collected the data.
Hypotension was defined as a 30% decrease of
systolic blood pressure compared with baseline,
bradycardia as heart rate inferior to 50 bpm, and
bradypnea as a respiratory rate less than 10
breaths/min. Sedation was recorded on a 4-point
scale (0¼no signs of sedation, 1¼mild sedation,
2¼moderate sedation, 3¼ severe sedation).
During the first 48h, the patients were visited by a
pain nurse from the Acute Pain Service and inter-
viewed regarding satisfaction with post-operative
analgesia. The patient judged the quality of pain man-
agement using a 4-point scale (1¼very dissatisfied,
2¼dissatisfied, 3¼ satisfied, 4¼very satisfied).
Statistical analysis
Results were expressed as means SDs for quantita-
tive variables and as frequencies for categorical
findings. Time-related VAS measurements were
summarized using different pain indicators as
described elsewhere (17): AUC: area under the VAS
time curve (cm2); mean VAS (cm); VAS max: peak of
VAS (cm); Tmax: time of VAS max (h); PVAS > 3: the
persistence of VAS over 3 cm, i.e. the time period
during which VAS was above the critical threshold
(h); Pdur: pain duration, i.e. the time period during
which the patient reported pain (VAS> 0) over the
Volume/concentration of levobupivacaine
885
48h (h). The comparison of mean values was done
using the ANOVA test, whereas proportions were
compared using the classic 2-test. The general linear
model (GLM) was used to analyse repeated measures
of continuous data. The GLM tests two null hypo-
theses as follows: (1) time has no effect on the variable,
which means that the variable mean of the combined
groups does not vary over time; and (2) the time
patterns are equal between the three groups, which
means that the difference between the mean of each
group is the same at every time-point. Bonferroni’s
test, based on Student’s t-statistic, was used for post
hoc testing. The number of patients included in the
study was based on our previous results and on a
power calculation assuming a 20% difference with
a¼ 0.05 and b¼ 0.20 (9, 19). All statistical calculations
were carried out by means of the SAS package (SAS
Institute, Cary, NC, version 6.12) and always using all
data available. Results were considered to be signifi-
cant at the 5% critical level (P< 0.05).
Results
Nine patients were excluded due to protocol devi-
ation, lack in data recording or accidental removal of
the catheter. A total of 90 patients with complete case
report forms were included in the study (26 in the
1.5mg/ml group, 33 in the 5mg/ml group and 31 in
the 7.5mg/ml group). In these patients, epidural
catheters were functioning until the end of the obser-
vation period. Patients’ characteristics and distribu-
tion according to the type of surgery are displayed
in Table 1. The demographic data baseline recordings
and the type of surgery were similar in the three
groups. Specifically, there was no difference in age
range between the three groups.
The level of insertion of the epidural catheter was
low thoracic (Th9—Th12), with no difference in the
three groups (P¼ 0.19). No cases of accidental dural
puncture occurred. At the time of surgery, patients
received the same amount of intravenous sufentanil
(25 11mg in the 1.5mg/ml group, 22 15mg in the
5mg/ml group and 20 8mg in the 7.5mg/ml group,
P¼ 0.28). There was a small difference between
groups in perioperative epidural levobupivacaine
used (54 19mg in the 1.5mg/ml group, 57 20mg
in the 5mg/ml group and 45 11mg in the 7.5mg/ml
group, P¼ 0.024). Mean upper level of sensory
blockade at the different time points after surgery
is illustrated in Fig. 1. Sensory block was more exten-
sive in the 1.5mg/ml group (Th7) compared with
the two other groups (Th9) (P< 0.001). We observed
a non-significant decline in the upper sensory block
after 28 h in the 1.5mg/ml group.
Figure 2 shows VAS pain scores during the first 48
post-operative hours in the three groups. GLM statis-
tics of the VAS scores for pain at rest did not show any
difference between the three groups. The values of the
pain indicators are displayed in Table 2. AUC, VAS
max, mean VAS and PVAS> 3 were similar in the
three groups. We found no relationship between the
type of surgery and the efficacy of pain relief.
Post-operative analgesic consumption is displayed
in Table 2. Propacetamol was given to all patients and
keterolac was administered to 25 (96%) patients in the
1.5mg/ml group, 28 (85%) in the 5mg/ml group and
26 (84%) patients in the 7.5mg/ml group (P¼ 0.30).
Table 1
Demographic and type of surgery in the three groups. Concentration








Sex (M/F) 8/18 14/19 7/24 0.23
Age (year) 59 12 60 13 58 13 0.68
Weight (kg) 73 14 74 17 72 15 0.83
Height (cm) 166 8 164 7 164 10 0.56
BMI (kg/m2) 27 4 28 6 27 5 0.59
ASA class 0.43
I 2 (9%) 8 (25%) 9 (29%)
II 16 (70%) 20 (63%) 18 (58%)
III 5 (21%) 4 (12%) 4 (13%)
Type of surgery 0.12
Urological (n) 3 8 4
Gynecological (n) 11 14 19
Visceral (n) 12 11 8
BMI: body mass index; ASA: American Society of Anesthesiologists.
Fig. 1. Mean upper sensory dermatomal level in the three groups of
patients during the 48-h (h) study period. Upper sensory levels
were higher in the low concentration group when compared with
the two other groups (P< 0.001 at all time points, general linear
model statistics). Concentration (1.5, 5 and 7.5mg/ml) refers to
levobupivacaine. Th: thoracic.
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Rescue analgesia, represented by morphine consump-
tion (PCA), was similar in the three groups. In the first
24h, the mean consumption of morphine was
10.7 10.1mg in the 1.5mg/ml group, compared
with 13.0 12.0mg for the 5mg/ml group and
16.111.7mg in the 7.5mg/ml group (P¼ 0.16). In
the second post-operative day, morphine use was
reduced to 8.0 7.1mg in the 1.5mg/ml group vs.
4.8 6.2mg in the 5mg/ml group and 5.3 6.0mg
in the 7.5mg/ml group (P¼ 0.09). No life-threatening
respiratory events associated with opioid administra-
tion were reported during the study period.
Nine (35%) patients in the 1.5mg/ml group suf-
fered nausea compared with 4 (12%) in the 5mg/ml
group and 3 (10%) in the 7.5mg/ml group
(P¼ 0.028). Vomiting was observed in 2 patients in
the 1.5mg/ml group, in 1 in each other group
(P¼ 0.63).
Motor blockade was consistently low in all patients
(mean Bromage scale inferior to I) without any differ-
ence between the groups. There was a significant
difference in haemodynamic parameters: systolic
and diastolic blood pressures were lower in the
1.5mg/ml group (Fig. 3; P< 0.001). GLM statistics
showed a highly significant time effect on the vari-
ables (P< 0.0001), a significantly different time
pattern (P< 0.001) as well as significantly different
overall means of the groups (P< 0.001). No relation-
ship could be established between age and haemo-
dynamic repercussions (odds ratio¼ 1.031; confidence
limits¼ 0.987—1.078; P¼ 0.166). Patients with low
blood pressure did not receive any antihypertensive
medication in the post-operative period. No vasocon-
strictors or atropine were given for treatment of hypo-
tension or bradycardia during the study period. No
sedation, respiratory depression or pruritus was
observed in any patient.
All patients of the three groups were satisfied or
very satisfied regarding the quality of pain manage-
ment.
Discussion
The results of the present study confirm that altering
the concentration and the volume of levobupivacaine
solution resulted in the same quality of analgesia after
thoracic epidural administration of an identical
amount of the local anaesthetic. These results are in
line with previous studies, supporting the view that
the quality of epidural analgesia depends on the total
mass of local anaesthetic and not on the volume
or concentration (2, 6, 9, 20, 21). The haemodynamic
Fig. 2. Mean visual analogue scale (VAS) scores expressed in
centimeter (cm) in the three groups of patients during the 48-h
study (h) period. No significant difference was found between the
three groups of patients (general linear model statistics).
Concentration (1.5, 5 and 7.5mg/ml) refers to levobupivacaine.
*P< 0.05 (ANOVA test).
Table 2








AUC (cm2) 23.1 29.3 26.7 29.0 30.3 34.4 0.68
VAS max (cm) 2.2 1.6 2.4 2.0 2.7 1.9 0.60
VAS mean (cm) 0.5 0.7 0.6 0.6 0.7 0.7 0.70
PVAS> 3 (h) 2.0 6.1 1.5 3.4 2.0 4.9 0.91
Morphine 24 h (mg) 10.7 10.1 13.0 12.0 16.1 12.0 0.16
Morphine 48 h (mg) 8.0 7.1 4.8 6.2 5.3 6.0 0.09
Propacetamol 24 h (g) 8 0 8 0 7.7 1.4 0.39
Propacetamol 48 h (g) 8 0 8 0 7.7 1.4 0.39
NSAIDs (n) 25 (96%) 28 (85%) 26 (84%) 0.30
Anti-emetic drugs (n) 4 (15%) 4 (12%) 4 (13%) 0.93




stability profile seems to be more stable in the higher
concentration groups. We used plain levobupivacaine
5mg/ml and 7.5mg/ml with continuous epidural
infusions at a low thoracic level. These concentrations
were selected to maximize the analgesic effects of the
local anaesthetic in the thoracoabdominal somato-
sensory distribution (22). Lower limb motor block
was consistently low in all patients and we did not
observe any difference between the three groups as
described in our previous study (9). The thoracic
approach minimizes motor and sympathetic blockade
of the lower limbs and could explain the low
incidence of side-effects (23). Avoidance of epidural
opioid may have contributed to the absence of
pruritus, sedation and respiratory depression. The
incidence of nausea was higher in the 1.5mg/ml
group. Patients were homogeneous regarding major
risk of post-operative nausea and vomiting (PONV),
e.g. gender, type of anaesthesia and surgery, pain,
morphine consumption and they received the same
anti-emetic prophylaxis (16, 24). Therefore we hypo-
thesized that a higher upper level of the block (Th7)
and a significantly lower blood pressure in this group
could have induced more nausea (25). The high
infusion rate (10ml/h) in the 1.5mg/ml group
explained the wider cephalad extend of the sensory
block. An upper level of Th7, about three segment
levels higher than needed for low abdominal surgery,
was determined by the study design of the trial. These
results do not support Bromage’s findings that the
spread of analgesia is independent of the volume.
Obviously the mass of the local anaesthetic defines
the quality of analgesia (6). These results are in accord-
ance with other studies (2, 4, 9). In the post-operative
period, Laveaux et al. (10) observed that the analgesic
efficacy and the occurrence of side-effects of a con-
tinuous thoracic epidural infusion of bupivacaine
with sufentanil at high concentration/low volume
vs. low concentration/high volume were similar.
These authors concluded that the total dose of the
local anaesthetic was more important than the con-
centration or the volume of the solution. Similar
results were reported by Mogensen et al. (11) and
Scott et al. (26)
However, as mentioned in the introduction section,
there are some discrepancies in the literature concern-
ing analgesic effect of the concentration of local
anaesthetics. After thoracic surgery, Snijdelaar et al.
(12) found better analgesia with high volume/low
concentration of epidural local anaesthetics com-
pared with a low volume/high concentration.
In their study, they used a smaller amount of bupi-
vacaine, i.e. 7.5—10mg/h compared with the 15mg/h
in our study. This fact could contribute to the higher
incidence of pain at rest their patients experienced.
Liu et al. (27), using patient-controlled epidural
analgesia (PCEA), observed that lesser concentrations
of a similar amount of epidural ropivacaine/fentanyl
provide equal analgesia with less motor blockade
after lower abdominal surgery. Epidural catheters
were placed at the Th12-L2 interspace. Placement of
catheters in proximity of lumbar spinal segments
increases the risk of motor block when compared
with a more cephalad approach (28). Whiteside et al.
(29), using the same association of drugs after gynae-
cological surgery, showed that a low concentration/
high volume PCEA appears satisfactory in treating
post-operative pain and reducing the dose of the
drugs used in comparison with a low volume/high
concentration. Our study differs considerably
because we used a continuous infusion of the local
anaesthetic rather than PCEA, and we did not add any
Fig. 3. Mean systolic (sys) and diastolic (dia) blood pressure (BP)
in the three groups of patients during the 48-h (h) study period.
Systolic and diastolic blood pressure expressed in mmHg was lower
in the 1.5mg/ml group when compared with the two other groups
at different time points (P¼ 0.0044, general linear model
statistics). Concentration (1.5, 5 and 7.5 mg/ml) refers to
levobupivacaine. *P< 0.05; **P< 0.01 (ANOVA test).
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opioids epidurally in order to focus only on local
anaesthetic action. Administration of a high volume
of fentanyl associated with the local anaesthetic could
produce more extensive sensory block as a result of
greater anatomic spread and interaction with opiate
receptors (26, 28). Opioids also limit the regression of
the sensory block observed with local anaesthetics
alone and improve the quality of pain relief (30). This
fact makes a comparison with our results difficult.
The most important limitation of our study design
is that only pain at rest was assessed. New experi-
ments must focus on pain during mobilization or
coughing. Furthermore, our patients received multi-
modal analgesia and were treated with systemic
analgesics that may have masked slight differences
in the intensity of rest pain between the three groups.
Further studies should also examine quality of anal-
gesia with other infusion rate modalities considering
that patients in the low concentration levobupivacaine
group, i.e. 1.5mg/ml, should have had a lower
infusion rate than that determined by the study
design. It should be noted that the plain 5 and
7.5mg/ml levobupivacaine solutions are ready to
use. Thereby the risk of administration errors
decreases as well as the nursing time and pharmacy
preparation costs.
In conclusion, continuous 5mg/ml and 7.5mg/ml
levobupivacaine given epidurally at the thoracic level
were equally effective as the same dose of a 1.5-mg/
ml solution in achieving adequate analgesia and with
better haemodynamic stability, lower cephalad extent
of sensory block and reduced incidence of nausea.
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